AACR Update
AACR Update
Research Advocate Seana Roubinek attended the 2015 American Association of Cancer Research Annual Meeting in April. Here is her report: “As a two-time cancer ovarian cancer survivor, I have had … Continued
News
New Affordable Care Act guidance says women with ovarian ca...
New Affordable Care Act guidance says women with ovarian cancer can receive free genetic counseling, testing
FOR IMMEDIATE RELEASE May 12, 2015 Contact: Lisa Mauti lmauti@ovariancancer.org (202) 517-6410 New Affordable Care Act guidance says women with ovarian cancer can receive free genetic counseling, testing WASHINGTON, DC—Yesterday, … Continued
ACA Update
ACA Update
New Affordable Care Act guidance says women with ovarian cancer can receive free genetic counseling, testing. On May 11, 2015, the U.S. Department of Health and Human Services, Labor and Treasury issued new guidance to clarify services and coverage available under the Affordable Care Act. Before today, only women with a family history of ovarian and breast cancer were eligible for genetic testing and counseling free from additional out-of-pocket expense. Click the plus sign to read on...
Pelvic Exam Guidelines
Pelvic Exam Guidelines
The American College of Physicians recently recommended that women do not need to have a pelvic exam on an annual basis. Current evidence suggests that the pelvic exam is not helpful as a routine screening test for women with an average risk of developing ovarian cancer.
Report from the 2014 American Society of Clinical Oncology ...
Report from the 2014 American Society of Clinical Oncology Annual Meeting
Promising new combination treatments for ovarian cancer Dr. Joyce Liu, MD, on behalf of researchers from the National Cancer Institute (NCI) and Dana Farber Cancer Institute (DFCI), presented striking results … Continued
2014 ASCO Research Round-Up
2014 ASCO Research Round-Up
Posted by Laura Koontz on June 5, 2014 The 50th Annual Conference of the American Society of Clinical Oncology, held May 30 – June 3 in Chicago, featured a number of promising and thought … Continued
Few women offered genetic counseling services for breast an...
Few women offered genetic counseling services for breast and ovarian cancer risk
Despite recommendations from the federal government that women at high-risk of developing breast and ovarian cancer be offered genetic counseling and testing at no out of pocket cost, a new … Continued
Alliance submits comments to FDA on off-label use of oncolo...
Alliance submits comments to FDA on off-label use of oncology drugs
This week, the Ovarian Cancer National Alliance submitted comments to the Food and Drug Administration (FDA) about a proposed Guidance for Industry that could have the effect of limiting patient … Continued
SGO and AACR Research Round-Up
SGO and AACR Research Round-Up
With two marquee scientific conferences, the Society for Gynecologic Oncology (SGO) and the American Association for Cancer Research (AACR), occurring back-to-back, the past few weeks have seen an explosion in … Continued
108 Members of the House of Representative Support Ovarian ...
108 Members of the House of Representative Support Ovarian Cancer Research Funding
Each spring, Congress takes up the task of allocating money to federal programs. And each spring, the Ovarian Cancer National Alliance works to ensure that ovarian cancer research funding remains … Continued
Updates from the 2014 Society for Gynecologic Oncology Annu...
Updates from the 2014 Society for Gynecologic Oncology Annual Meeting
Compiled by Robin Cohen, President-Elect, Ovarian Cancer National Alliance As in years past, a wealth of clinical research into ovarian cancer was presented at the 2014 Society for Gynecologic Oncology … Continued
Vynfinit gains European approval for treatment of platinum-...
Vynfinit gains European approval for treatment of platinum-resistant ovarian cancer
Last week, the European Medicines Agency’s Committee for Medicinal Products for Human Use, or CHMP – the equivalent to the FDA in the United States, recommended approval for vynfinit in … Continued